60 DEGREES PHARMACEUTICALS INC
For the period ended Sep 30, 2024. Filed Nov 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 14, 2024
SXTP$0.52-4.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
EXHIBIT INDEX
| Exhibit No. | Description |
| 4.1 | Form of Pre-Funded Warrant (Incorporated by reference to the same exhibit number in the Company’s Registration Statement, as amended (File No. 001-41719), filed with the Securities and Exchange Commission on September 6, 2024) |
| 4.2 | Form of Series A Warrants (Incorporated by reference to the same exhibit number in the Company’s Registration Statement, as amended (File No. 001-41719), filed with the Securities and Exchange Commission on September 6, 2024) |
| 4.3 | Form of Series B Warrants (Incorporated by reference to the same exhibit number in the Company’s Registration Statement, as amended (File No. 001-41719), filed with the Securities and Exchange Commission on September 6, 2024) |
| 4.4 | Form of Placement Agent Warrant (Incorporated by reference to the same exhibit number in the Company’s Registration Statement, as amended (File No. 001-41719), filed with the Securities and Exchange Commission on September 6, 2024) |
| 10.1 | Form of Placement Agent Warrant (Incorporated by reference to the same exhibit number in the Company’s Registration Statement, as amended (File No. 001-41719), filed with the Securities and Exchange Commission on September 6, 2024) |
| 10.2 | Form of Registration Rights Agreement (Incorporated by reference to the same exhibit number in the Company’s Registration Statement, as amended (File No. 001-41719), filed with the Securities and Exchange Commission on September 6, 202) |
| 31.1* | Rule 13a-14(a)/15d-14(a) Certification of the President and Chief Executive Officer of 60 Degrees Pharmaceuticals, Inc. |
| 31.2* | Rule 13a-14(a)/15d-14(a) Certification of the Chief Financial Officer of 60 Degrees Pharmaceuticals, Inc. |
| 32.1** | Section 1350 Certification of the President and Chief Executive Officer of 60 Degrees Pharmaceuticals, Inc. |
| 32.2** | Section 1350 Certification of the Chief Financial Officer of 60 Degrees Pharmaceuticals, Inc. |
| 101.INS* | Inline XBRL Instance Document |
| 101.SCH* | Inline XBRL Taxonomy Extension Schema Document |
| 101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB* | Inline XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 104* | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
| * | Filed herewith. |
|---|---|
| ** | Exhibits 32.1 and 32.2 are being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall such exhibits be deemed to be incorporated by reference in any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise specifically stated in such filing. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.